approach end took anoth look model ep estim
unchang revenu forecast trim fx rais slightli
pend aratana acquisit reiter outperform pt
maintain full year ep estim line guidanc
vs consensu model assum aratana acquisit
close neutral ep ep estim also intact
estim compound-annual-growth-rate
lower revenu estim line
guidanc vs consensu neg currenc
impact offset addit aratana product nocita entyc estim add
rais revenu forecast
year aratana product sale compound-annual-growth-rate unchang
rais oper margin forecast
year reach numer cost reduct initi put
place past year begin show benefit evidenc gpm
estim
african swine fever asf modest near term overhang anim
health compani impact asf elanco estim full
year impact project elanco expect off-set loss revenu
sale market suppli increas protein demand
pork altern expect rise pleas join us thursday june
et webinar african swine fever protein predica lanc zimmerman
cattlefax information/analysi provid beef agricultur industri
topic includ quantif asf impact global suppli demand import/
export trend china impact protein rise pork price current
trade situat influenc asf supply/demand dynam comparison asf pedv
break-out call co-host cowen restaur andrew charl chemic
charli neivert pharma/anim kathi miner analyst dial-in inform
pleas contact cowen salesperson
pleas see page report import disclosur
signific opportun stabl annual growth visibl anim
market driven global demand protein uptick new companion anim
drug elanco anim health compani decad experi strong
reput veterinari market one stand-alon publicli trade larg
anim health compani elanco offer investor opportun particip
closur aratana acquisit late
sale compound-annual-growth-rate
ep compound-annual-growth-rate
faster expect
emerg signific product
pipelin
greater expect profit
effici improv take longer
less meaning
elanco spun-out septemb public stand-alone compani ipo
lilli retain ownership march elanco fulli spun
lilli elanco anim health busi sinc elanco largest
compani global anim health market sale brand
sale countri
compani data cowen compani
compani data cowen compani
compani data cowen compani
compani data cowen compani
anim prevent parasiticid vaccin trifexi credelio interceptor other ex assum competit headwind start anim therapeut gallipr onsior other aratana add nocita entyc ex upsid potenti new product bolt-onsfood anim futur protein health poultri ionophor vaccin parasiticid probiotci etc poultri aquacultur ex swine shared/non-shar antibiot parasiticid implant ex target segmenttot enu ex report -- -- -- -- -- distribut agreement contact mfg equin producttot enu growth possibl upsid pipelin local currenc ex cowen
compani data cowen compani
valuat methodolog primarili base current year forward price-to-earnings multipl
also consid total return/p ratio discount cash flow
competit dynam global potenti regulatori delay reject failur
and/or polit uncertainti emerg market chang tax law outlook
dividend fluctuat foreign exchang rate
abil transit product mix gener revenu growth success
pipelin continu execut oper improv plan weather/disease/
polit risk busi success independ compani
author research report herebi certifi view express research report accur reflect person view subject
secur issuer ii part compens relat directli indirectli specif recommend view express report
cowen compani llc affili make market stock novarti adr roch hold ltd adr secur
cowen compani llc act underwrit announc initi public offer elanco anim health incorpor subsidiari co
cowen compani llc act financi advisor inc connect acquisit roch hold ag announc februari
cowen compani llc manag co-manag public offer past month
cowen compani llc receiv compens invest bank servic past month
past month client cowen compani llc cowen compani llc provid provid invest bank servic
past month
cowen compani llc compens research analyst activ servic intend benefit firm investor client individu compens determin research
analyst includ author report base varieti factor includ overal profit firm total revenu deriv sourc includ
revenu invest bank sale trade princip trade revenu cowen compani llc compens research analyst base specif invest
bank transact specif sale trade princip trade revenu
research report simultan avail client client websit research report client research report dissemin e-mail
made avail third-parti aggreg cowen compani llc respons redistribut research third parti aggreg select research report
avail print form addit electron form publish research report obtain firm client websit http //cowenlibrari bluematrix com/client/
inform opinion estim forecast date report subject chang without prior notif seek updat research appropri
variou regul may prevent us research report publish irregular interv appropri analyst judgement
inform subject secur may obtain offic research report publish sole inform purpos constru offer
sell solicit offer buy secur state offer solicit would illeg disclosur relat cowen compani llc
